Navigation Links
Interim Analysis Supports Continuation of Cell Genesys' VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer
Date:1/14/2008

Conference Call Scheduled for 10:00 a.m. ET Today

SOUTH SAN FRANCISCO, Calif., Jan. 14 /PRNewswire-FirstCall/ -- Cell Genesys, Inc. (Nasdaq: CEGE) today announced that the Independent Data Monitoring Committee (IDMC) for VITAL-1, the first of two ongoing Phase 3 clinical trials of GVAX immunotherapy for prostate cancer, has completed a pre-planned interim analysis and has recommended that the study continue. This event-driven interim analysis was designed to determine whether the study should continue to completion and took place in the time frame originally estimated. As is customary to preserve study blinding, the IDMC provided no information to the company other than the recommendation to continue the trial.

"The IDMC's recommendation to continue with the VITAL-1 trial represents an important step forward in the Phase 3 development of GVAX immunotherapy for prostate cancer and in our effort to make this product available as a new treatment option for men with prostate cancer," stated Robert Dow, MBChB, chief medical officer of Cell Genesys. "Moreover, we can currently estimate that we will reach the required number of events needed to conduct the final analysis in the second half of 2009."

VITAL-1 is a multi-center, randomized, controlled Phase 3 clinical trial designed to compare GVAX cancer immunotherapy to Taxotere(R) (docetaxel) chemotherapy plus prednisone in hormone refractory prostate cancer (HRPC) patients with metastatic disease who are asymptomatic with respect to cancer- related pain. The primary endpoint of the trial is an improvement in survival. VITAL-1 was initiated in July 2004 and completed recruitment of 626 patients in July 2007. Patients were enrolled at approximately 130 sites in North
'/>"/>

SOURCE Cell Genesys, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
2. Interim Response and Safety Analyses Support Continuation of Allos Therapeutics Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-Cell Lymphoma
3. Immtech Announces Interim Analysis in Phase III African Sleeping Sickness Trial
4. Interim Safety Data Favorable for Vicals Phase 2 Trial of DNA Vaccine Against CMV
5. Interim Phase 2 Data for Exelixis XL880 Show Anti-Tumor Activity in Papillary Renal Cell Cancer
6. Leading Physicians Present Interim Results from Multi-Center Studies of VNUS ClosureFAST Catheter at VEITHsymposium
7. Grantees of the Avon Foundation Breast Cancer Prevention Research Initiative Gather in Houston to Report Interim Findings
8. Novavax Announces Favorable Interim Results from Human Clinical Trial for Its Pandemic Influenza Vaccine Program
9. Interim Safety Analysis Supports Continuation of Allos Therapeutics Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-cell Lymphoma
10. Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis
11. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... -- Lannett Company, Inc. (NYSE: LCI ) today ... ended March 31, 2015.  For the ... $99.4 million from $80.0 million in last year,s third ... 76% of net sales, from $56.1 million, or 70% ... to $9.2 million from $10.6 million for the fiscal ...
(Date:5/6/2015)... , May 6, 2015 The Parenteral ... it has finalized agreement with Richard M. Johnson ... "We are very pleased to have ... said Hal Baseman , the Chair of the ... success, performance and growth.  Richard has led a strong ...
(Date:5/6/2015)... , May 06, 2015 Research and ... the addition of the "Cannulas Market by ... Injector, Infusion, Venous, Microcannula), Material (Plastic, Metal) & ... Forecast to 2020" report to their offering. ... to grow at a CAGR of 5.6% from ...
Breaking Medicine Technology:Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 2Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 3Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 4Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 5Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 6Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 7Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 8PDA Extends Richard M. Johnson as President/CEO for Six Additional Years 2Global Cannulas Market 2015 - Forecasts to 2020 with Medtronic, Edward Lifesciences, Terumo, Sorin & Maquet Holding B.V. & Co. Dominating 2Global Cannulas Market 2015 - Forecasts to 2020 with Medtronic, Edward Lifesciences, Terumo, Sorin & Maquet Holding B.V. & Co. Dominating 3
... 10 Alliance Seating & Mobility ... who have an Assistive Technology Professional (ATP) certification ... North America (RESNA). However, ATPs are hard to ... launched an internal development program for existing employee-owners ...
... Reportlinker.com announces that a new market ... , Injectable Drug Delivery: Market ... http://www.reportlinker.com/p0158352/Injectable-Drug-Delivery-Market-Impact-and-Industry-Trends.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire , As ... are increasingly looking towards the drug delivery ...
Cached Medicine Technology:Alliance Seating & Mobility Launches Its ATP Development Program 2Reportlinker Adds Injectable Drug Delivery: Market Impact and Industry Trends 2Reportlinker Adds Injectable Drug Delivery: Market Impact and Industry Trends 3Reportlinker Adds Injectable Drug Delivery: Market Impact and Industry Trends 4Reportlinker Adds Injectable Drug Delivery: Market Impact and Industry Trends 5Reportlinker Adds Injectable Drug Delivery: Market Impact and Industry Trends 6
(Date:5/6/2015)... Baltimore, MD (PRWEB) May 06, 2015 The ... Baltimore Ravens for the 6th annual charity softball ... 7:00pm at M & T Bank Stadium. Past years guests ... among others. Tickets are still on sale if ... been advocating for local non-profit organizations, such as SOAR ...
(Date:5/6/2015)... 2015 Baptist Medical Center Jacksonville ... in north Florida and southeast Georgia region offering ... innovation in total hip replacement surgery performed using ... arm that enables the accurate alignment and positioning ... offered MAKOplasty® partial knee resurfacing using the RIO ...
(Date:5/6/2015)... King of Prussia, PA (PRWEB) May 06, 2015 ... Business Process Outsourcing solutions to the Medicare Advantage, Medicare ... three finalists in the Continuity and Resilience Team category ... by the Business Continuity Institute to recognize the outstanding ... or operating in the North America Region, including the ...
(Date:5/6/2015)... “ SideChef ” was featured on NewsWatch as part ... and coolest applications on the market for iOS, Android, and Windows. ... app review and shared with viewers how this application walks users ... be a good navigator people had to know how to read ... a master navigator. Well what if people could “GPS” their way ...
(Date:5/6/2015)... Marketing Maven announces a continued partnership ... hygiene nonprofit by GuideStar’s Philanthropedia. , “WaterAid is doing ... brings our agency great joy to work with them,” ... relationship between WaterAid and Marketing Maven will ... and support the nonprofit as they aim to provide ...
Breaking Medicine News(10 mins):Health News:The Canton Group Sponsors Ravens Charity Softball Event 2Health News:The Canton Group Sponsors Ravens Charity Softball Event 3Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 2Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 3Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 4Health News:TMG Health Recognized by the Business Continuity Institute 2Health News:TMG Health Recognized by the Business Continuity Institute 3Health News:An Application to Guide Users through Recipes Was Featured on NewsWatch Television 2Health News:Marketing Maven Expands Partnership with the #1 Ranked International Water, Sanitation and Hygiene Nonprofit 2Health News:Marketing Maven Expands Partnership with the #1 Ranked International Water, Sanitation and Hygiene Nonprofit 3
... 10 portionpals(R), the fastest growing,weight loss tool ... million,sales mark with no national retail distribution in ... are coming strictly from word-of-mouth," says Matt,Zucker, VP ... Moose,of Manistique, Michigan became our 250,000 customer! "Our ...
... that first-degree relatives (i.e., parents, siblings, children) of patients ... have the biomarker of the disease in their blood. ... assess first-degree relatives of PBC patients with a simple ... patients before the disease causes irreversible liver damage. These ...
... well after therapy ends , , MONDAY, Sept. 10 (HealthDay ... breast cancer survivors still report more days of fatigue ... fatigue is likely a long-term effect of chemotherapy, according ... complaint for most people and is also reported by ...
... blocked heart arteries a key question has persisted for ... abciximab, justified over use of the less-expensive eptifibatide" ... in the current edition of Value in Health, Volume ... offers clinicians the first large-scale contemporary study to help ...
... Safety: Innovative Solutions and Tools set for fall ... ... Risk Management and,Patient Safety Institute (RM&PSI) today announced the dates, topics ... FinCor Holdings Inc. (http://www.fincorholdings.com ), is a national,leader in risk ...
... Software optimizes coding accuracy and turn-around time for ... Solutions, a leader in,health information management (HIM) services ... coding capabilities with,PrecyseCode 2X. The key enhancement to ... ensures greater security of the medical record,and greater ...
Cached Medicine News:Health News:New research may lead to earlier diagnosis and treatment of primary biliary cirrhosis in families 2Health News:Long-Term Fatigue Plagues Cancer Survivors 2Health News:The Risk Management and Patient Safety Institute Announces Annual Health Care Risk Conference Dates 2Health News:Enhanced PrecyseCode 2X(TM) Further Accelerates Remote Coding and Improves Cash Flow for Hospitals 2Health News:Enhanced PrecyseCode 2X(TM) Further Accelerates Remote Coding and Improves Cash Flow for Hospitals 3
Inquire...
Inquire...
Inquire...
Single-action scissors offer fine-pointed, sharp dissecting jaws to facilitate a partial cut in the cystic duct in preparation for a cholangiogram. They are tapered at the tip for greater visualizati...
Medicine Products: